Incannex Healthcare Inc.
A clinical-stage biopharma firm developing cannabinoid and psychedelic-based therapies.
IXHL | US
Overview
Corporate Details
- ISIN(s):
- US45333L1061
- LEI:
- Country:
- United States of America
- Address:
- 8 CENTURY CIRCUIT, 0 NORWEST NSW
- Website:
- http://www.incannex.com
Description
Incannex Healthcare Inc. is a clinical-stage biopharmaceutical company focused on the research and development of medicinal cannabinoid and psychedelic-based therapies. The company develops proprietary pharmaceutical products for conditions with significant unmet medical needs, including obstructive sleep apnea, traumatic brain injury, and inflammatory diseases. Its core activity involves advancing a diverse pipeline of drug candidates through rigorous clinical trials and regulatory pathways, primarily with the U.S. Food and Drug Administration (FDA). Incannex aims to deliver innovative, regulated medicines by targeting the underlying biological mechanisms of chronic conditions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Incannex Healthcare Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Incannex Healthcare Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Incannex Healthcare Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
